BEGIN:VCALENDAR VERSION:2.0 PRODID:-//Society of Cannabis Clinicians - ECPv6.15.15//NONSGML v1.0//EN CALSCALE:GREGORIAN METHOD:PUBLISH X-WR-CALNAME:Society of Cannabis Clinicians X-ORIGINAL-URL:https://www.cannabisclinicians.org X-WR-CALDESC:Events for Society of Cannabis Clinicians REFRESH-INTERVAL;VALUE=DURATION:PT1H X-Robots-Tag:noindex X-PUBLISHED-TTL:PT1H BEGIN:VTIMEZONE TZID:America/Los_Angeles BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20200308T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20201101T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20210314T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20211107T090000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0800 TZOFFSETTO:-0700 TZNAME:PDT DTSTART:20220313T100000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0700 TZOFFSETTO:-0800 TZNAME:PST DTSTART:20221106T090000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Bogota BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0500 TZNAME:-05 DTSTART:20200101T000000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/New_York BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20200308T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20201101T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20210314T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20211107T060000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0500 TZOFFSETTO:-0400 TZNAME:EDT DTSTART:20220313T070000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0400 TZOFFSETTO:-0500 TZNAME:EST DTSTART:20221106T060000 END:STANDARD END:VTIMEZONE BEGIN:VTIMEZONE TZID:America/Mexico_City BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20200405T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20201025T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20210404T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20211031T070000 END:STANDARD BEGIN:DAYLIGHT TZOFFSETFROM:-0600 TZOFFSETTO:-0500 TZNAME:CDT DTSTART:20220403T080000 END:DAYLIGHT BEGIN:STANDARD TZOFFSETFROM:-0500 TZOFFSETTO:-0600 TZNAME:CST DTSTART:20221030T070000 END:STANDARD END:VTIMEZONE BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20211105T090000 DTEND;TZID=America/Los_Angeles:20211105T100000 DTSTAMP:20260604T121701 CREATED:20210908T161749Z LAST-MODIFIED:20210909T090225Z UID:10000088-1636102800-1636106400@www.cannabisclinicians.org SUMMARY:Monthly Journal Club: Mariana Maciel\, MD on Water-soluble Nano-enhanced Cannabinoid Medicines DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear Dr. Maciel discuss evidence about water-soluble nano-enhanced cannabinoid medicines and their applicability\, safety and how they differ from oil products. \nPresenter:\nMariana Maciel\, MD (bio below) \nTopic:\nWater-soluble Nano-enhanced Cannabinoid Medicines \nArticle to be Discussed:\n\nTowards Better Delivery of Cannabidiol (CBD)\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nMariana Maciel\, MD is a physician graduated at the Faculty of Medicine of Barbacena and completed her residency in Internal Medicine. She worked in Brazil in clinical ward\, urgency / emergency\, SAMU (paramedic)\, intensive care\, and family medicine. She worked with research\, article publishing and attended an internship at Charles University (CZ). She also has teaching experience at Universidade Federal de Viçosa. \nAlthough she was progressing in her medical career in Brazil\, Dr. Mariana chose to move to Canada in search of new opportunities and a better quality of life. In Canada\, in addition to getting married and becoming a mother\, she leveraged her career by specializing in Medicinal Cannabis and Cannabinoid Medicine. In Vancouver\, she is part of a Medicinal Cannabis clinic team. Her entrepreneurial profile added to her values of holistic and integral medicine which gave rise to Thronus Medical and Thronus Education. Dr. Mariana has put into practice her mission to transform and inspire people’s lives through medical education and the development of innovative cannabis-derived products. URL:https://www.cannabisclinicians.org/event/journal-club-mariana-maciel-md-on-water-soluble-nano-enhanced-cannabinoid-medicines/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20211014T090000 DTEND;TZID=America/Los_Angeles:20211014T100000 DTSTAMP:20260604T121701 CREATED:20210929T134028Z LAST-MODIFIED:20211001T074250Z UID:10000093-1634202000-1634205600@www.cannabisclinicians.org SUMMARY:Legal Concerns for the Cannabis Healthcare Professional DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nWith cannabis remaining classified as a Schedule I drug under the federal Controlled Substances Act in the United States\, legal concerns for clinicians practicing cannabinoid medicine remain high. Join us for this informational session when SCC member Richard Cheng\, JD CHC will share what he has learned about the issues that healthcare professionals face when entering this clinical realm. \nThe SCC is excited to announce the alliance with INCBA (the International Cannabis Bar Association)\, a membership organization led by Christopher Davis. Their mission is to raise the standard of legal services available to the cannabis industry\, to advocate for the lawyers’ right to represent cannabis industry participants\, and to help build a solid foundation upon which the cannabis industry can sustainably thrive for years to come. Through our alliance\, SCC will serve as a resource to INCBA members providing research studies and medical expertise for clinical cases. Also INCBA members will address questions from SCC members facing legal issues and provide pro bono support when available. \nPresenters:\n \nChristopher Davis\, Esq\nExecutive Director\, International Cannabis Bar Association\nPartnership announcement of SCC & INCBA; History and goals of INCBA \nRichard Cheng\, JD\, CHC\nHealthcare Attorney with Speciality in Cannabis \nTopics to be discussed:\nOverview of the current legal status for cannabis: \n\nHow cannabis is viewed by the public\nFederal and state prohibitions\nFederal protections\nPhysician concerns with cannabis\nLegal concerns and practices by facility based providers\nHealthcare fraud issues in cannabis\nAncillary concerns (e.g. contracts\, banking\, leases)\n\nFREE for SCC members. $10 for non members.  \n  \nREGISTRATION >> URL:https://www.cannabisclinicians.org/event/legal-concerns-for-the-cannabis-healthcare-professional/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/09/pexels-photo-5668481.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20211010T120000 DTEND;TZID=America/Los_Angeles:20211010T140000 DTSTAMP:20260604T121701 CREATED:20210924T085737Z LAST-MODIFIED:20210928T095446Z UID:10000091-1633867200-1633874400@www.cannabisclinicians.org SUMMARY:Quarterly Meeting: The International Phytomedicine and Medical Cannabis Institute: High Impact Areas and Opportunities for Collaboration with Wilfred Ngwa\, MS\, PhD DESCRIPTION:Join us for our quarterly meeting with featured speaker Wilfred Ngwa\, MS\, PhD. Dr. Ngwa will be discussing The International Phytomedicine and Medical Cannabis Institute: High impact areas and opportunities for collaboration with the USA. You may learn more about Dr. Ngwa’s work in the bio below. \nThe meeting is remote and free to all SCC members. Non members can also join for $10. Members can log in to the membership portal for instructions on how to join. \n  \nRSVP >> \n  \n \nWilfred Ngwa\, MS\, PhD has won 17 prestigious awards and honors over the past five years from Harvard\, the United States National Institutes of Health\, and international professional societies and organizations for his leading efforts in global health. His work has led to the establishment of new healthcare institutions and cancer centers in low and middle income countries. He has also trained thousands of healthcare professionals\, and established win-win collaborations for global health and economic development. He also is: \n\nDirector of the International Phytomedicine and Medical Cannabis Institute launched at Harvard in 2019\nA Distinguished Professor of Public Health ICT\nDirector of the Global Health Catalyst at Johns Hopkins and founding Director of the same program launched at Harvard Radcliffe institute in 2015 with afocus on catalyzing high impact collaborations for global health and development\nChair of the Lancet Oncology Commission for Sub-Saharan Africa\nFounder of the Global Oncology University\, an award-winning collaborative education model that offers everyone access to the same world class education and training available from professors at the world’s best institutions.\nCo-Director of the Africa-Oxford-Harvard (AfrOX-H) Clinical Trials network\nCurrently serves as Advisor for the USA government on Global Health URL:https://www.cannabisclinicians.org/event/quarterly-meeting-international-phytomedicine-and-medical-cannabis-institute-at-harvard-with-wilfred-ngwa/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/06/Quarterly-Meeting-website-banner.jpg ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20211001T090000 DTEND;TZID=America/Los_Angeles:20211001T100000 DTSTAMP:20260604T121701 CREATED:20210915T152032Z LAST-MODIFIED:20210921T132607Z UID:10000089-1633078800-1633082400@www.cannabisclinicians.org SUMMARY:Monthly Journal Club: Dylan Zylla\, MD on Cannabis for Stage IV Cancer- Dosage\, Safety\, and Impact on Pain DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month’s installment will hear from Dylan Zylla\, MD as he discusses the applications of cannabis for stage IV cancer\, dosing\, the impact on pain\, and patient safety. \nPresenter:\nDylan Zylla\, MD (bio below) \nTopic:\nA randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility\, dose requirements\, impact on pain and opioid use\, safety\, and overall patient satisfaction. \nArticle to be Discussed:\n\nA randomized trial of medical cannabis in patients with stage IV cancers to assess feasibility\, dose requirements\, impact on pain and opioid use\, safety\, and overall patient satisfaction\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nDylan Zylla\, MD is a hematologist/oncologist working to answer key questions in clinical oncology and improve pain and symptom management among patients with cancer. He integrates research into his clinical practice with protected research time and access to an institution with a strong reputation in quantitative\, qualitative and clinical research. He is a site principal investigator on multiple industry-sponsored oncology clinical trials. His projects focus on cancer pain\, the mu-opioid receptor\, and novel ways to treat pain. He was a key member of the Minnesota Community Measurement’s work group that developed quality measures for cancer symptom control using patient-reported outcomes (PROs)\, and he collaborates with national leaders on integrating electronic PROs into cancer care. \nSince 2016\, Dr. Zylla has spearheaded large-scale efforts to address how cannabis impacts the lives of patients with cancer. He led the Cannabis in Cancer (CanCan) study which randomized patients with metastatic cancers to receive early vs delayed cannabis to treat symptoms. In 2018\, he published a survey of medical oncology professionals in Minnesota and demonstrated most clinicians support cannabis use for their patients. In collaboration with the Minnesota Department of Health\, he analyzed surveys of over 1\,000 patients with cancer\, certified in the state’s cannabis program since 2015. They found that those patients experienced significant clinical improvement in a variety of symptoms and reported few serious adverse events. \nRecently completed projects:\n• A randomized trial of cannabis in patients with stage IV cancers to assess dose requirements\, impact on pain and opioid use\, and overall patient satisfaction.\n• Impact of pain\, opioids\, and the mu-opioid receptor on progression and survival in patients with newly diagnosed stage IV pancreatic cancer. This project developed a novel immunohistochemical assay to determine the level of a mu-opioid receptor on a cancer cell. \nProjects in development include:\n• Cannabis registry on experience using cannabis\, including over-the-counter cannabidiol (CBD)\n• Topical cannabis/CBD creams for pain\n• Impact of medical cannabis for patients with newly diagnosed\, stage IV pancreas cancer\n• Cannabis as an anti-cancer agent\n• Mu-opioid receptor expansion project\n• Improving assessment and management of hyperglycemia in patients with diabetes and cancer URL:https://www.cannabisclinicians.org/event/monthly-journal-club-dylan-zylla-on-cannabis-for-stage-iv-cancer-dosage-impact-on-pain-and-safety/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210923T090000 DTEND;TZID=America/Los_Angeles:20210923T100000 DTSTAMP:20260604T121701 CREATED:20210811T151340Z LAST-MODIFIED:20210811T151340Z UID:10000087-1632387600-1632391200@www.cannabisclinicians.org SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis for Health Promotion & Disease Prevention with Dustin Sulak\, DO DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the September edition of “Canna Talk with Frye and Wilson-King” on September 23rd as we explore cannabis for health promotion and disease prevention with Dustin Sulak\, DO.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Sulak and discuss how he was introduced to cannabinoid medicine\, what inspired his particular specialty\, and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Sulak presented in his SCC Clinical Training Module Cannabis for Health Promotion & Disease Prevention. Learn more in his bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \n \nDustin Sulak\, D.O. is an osteopathic physician\, licensed in Maine as a general practitioner. He is an expert in integrative medicine\, the intelligent combination of conventional and alternative approaches to healthcare. He has long been fascinated by mind-body medicine\, spirituality in healthcare\, and natural approaches to promoting health and healing. He is an expert in cranial and biodynamic osteopathy\, a clinical hypnotherapist\, Reiki sensei\, practitioner of chi kung and yoga\, and has studied with numerous conventional and alternative healers and physicians. \nDr. Sulak’s clinical practice focuses on treating refractory conditions in adults and children.  He received undergraduate degrees in nutrition science and biology from Indiana University\, a doctorate of osteopathy from the Arizona College of Osteopathic Medicine\, and completed an osteopathic internship at Maine-Dartmouth Family Medicine Residency.  Dr. Sulak is the founder of Integr8 Health and Healer.com\, a medical cannabis education resource.  He is a passionate teacher of clinicians\, patients and industry professionals\, and sits on the board of directors of two nonprofits focused on cannabis education\, The Society of Cannabis Clinicians and Patients Out of Time. URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-for-health-promotion-disease-prevention-with-dustin-sulak-md/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210827T090000 DTEND;TZID=America/Los_Angeles:20210827T100000 DTSTAMP:20260604T121701 CREATED:20210526T131956Z LAST-MODIFIED:20210526T132358Z UID:10000084-1630054800-1630058400@www.cannabisclinicians.org SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis in Geriatrics with Mikhail Kogan\, MD DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the August edition of “Canna Talk with Frye and Wilson-King” on August 27th as we explore cannabis in geriatrics and assisted living with Mikhail Kogan\, MD.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Kogan and discuss how he was introduced to cannabinoid medicine\, what inspired his particular specialty\, and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Walsh presented in his SCC Clinical Training Module Cannabis in Geriatrics & Assisted Living. Learn more in his bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nMikhail Kogan\, MD\, ABOIM is board-certified in Internal Medicine\, Geriatrics\, Palliative Care\, and Integrative Medicine. Dr. Kogan is a leader in the newly established field of Integrative Geriatrics.  He is the editor of “Integrative Geriatric Medicine” Oxford University Press textbook. He is board-certified in Internal Medicine\, Geriatrics\, Palliative Care\, and Integrative Medicine. Dr Kogan is currently serves as medical director of the GW Center for Integrative Medicine\, associate director of the Geriatric and Integrative Medicine Fellowships at the George Washington University School of Medicine.  Dr Kogan has been early adopter of DC Medical Cannabis program and has been instrumental in DC Rx Medical Cannabis education program.  Dr Kogan is a frequent speaker at a variety of international conferences and has multiple media appearances related to medical cannabis. At present Dr Kogan is conducting pilot research program on assessing non psychoactive forms of cannabis such as CBD and CBDa for neurodegenerative conditions such as Alzheimer’s and Parkinson’s Diseases. URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-in-geriatrics-with-mikhail-kogan-md/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210820T090000 DTEND;TZID=America/Los_Angeles:20210820T103000 DTSTAMP:20260604T121701 CREATED:20210526T080619Z LAST-MODIFIED:20210714T064837Z UID:10000081-1629450000-1629455400@www.cannabisclinicians.org SUMMARY:Special Edition of Journal Club: Dr. Ethan Russo & Nishi Whiteley on Cannabinoid Hyperemesis Syndrome DESCRIPTION:9-10am PST / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nPresenters: \n\nEthan Russo\nNishi Whiteley\n\n(read their bios below) \nTopic: \nCannabinoid Hyperemesis Syndrome: An Emerging Public Health Problem with a Genetic Basis \nArticle: \nCannabinoid Hyperemesis Syndrome Survey and Genomic Investigation (Cannabis and Cannabinoid Research\, 2021) \nOverview \nIs cannabinoid hyperemesis syndrome (CHS) associated with genetic mutations that might explain its unusual pathophysiology\, symptoms\, and signs? This topic is what Ethan Russo\, MD and Nishi Whiteley will be discussing in this special edition of Journal Club on August 20th. Their presentation will center around the findings\, implications\, and what the research illuminates about the daily life\, habits and susceptibilities of CHS patients based on their recent paper “Cannabinoid Hyperemesis Syndrome Survey and Genomic Investigation”. This event marks the first time that Dr. Russo and Nishi Whiteley will be presenting their findings to a physicians’ group. \nThe largest survey of CHS to date (205 CHS patients plus 54 controls after screening) was conducted by Dr. Russo and colleagues that confirmed clinical patterns of nausea\, vomiting\, abdominal pain\, and hot water bathing behavior associated with chronic high tetrahydrocannabinol (THC) exposure. Genomic testing in 28 CHS patients with firm diagnosis and ongoing associated symptoms vs. 12 controls who used cannabis but did not display symptoms and signs revealed five statistically significant mutations affecting TRPV1\, CYP2C9 coding the catabolic enzyme of THC\, DRD2 and COMT\, two genes affecting dopaminergic function\, and ABCA1\, the ATP-binding cassette transporter affecting cholesterol efflux. \nMeaning: These results establish a genetic etiology of susceptibility to development of CHS with high level THC exposure\, elucidate the associated pathologies of CHS\, and may represent a practical screening device that could point to more effective therapeutic interventions. Have the opportunity to ask questions and delve into the research with the authors of this exciting new research paper. \nThe event is FREE for SCC members. $10 for non members. \n  \nREGISTER >> \n  \n \nEthan Russo\, MD is a board-certified neurologist\, psychopharmacology researcher\, and author. He is the Founder and CEO of CannabisResearch.org. He has 24 years of clinical cannabis research experience. He has authored 50+ peer-reviewed journal articles and seven books. \nPreviously\, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague\, Czech Republic\, Medical Director of PHYTECS (2015-2017)\, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system\, and from 2003-2014\, he served as Senior Medical Advisor\, medical monitor and study physician to GW Pharmaceuticals\, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy. \nHe has held faculty appointments in Pharmaceutical Sciences at the University of Montana\, in Medicine at the University of Washington\, and as visiting professor\, Chinese Academy of Sciences\, Harvard University\, and Johns Hopkins University. \nHe is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs\, co-editor of Cannabis and Cannabinoids: Pharmacology\, Toxicology and Therapeutic Potential\, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics\, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS\, Women and Cannabis: Medicine\, Science and Sociology\, Cannabis: From Pariah to Prescription\, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He has also published numerous book chapters\, and over fifty articles in neurology\, pain management\, cannabis\, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms\, phytopharmaceutical treatment of migraine and chronic pain\, herbal synergy and phytocannabinoid/terpenoid\, serotonergic and vanilloid interactions. \nHe has consulted or lectured on these topics in 39 US states and Canadian provinces and 39 countries. \nNishi Whiteley (pronounced Nee-sha)\, is the co-founder and Chief Operating Officer of CReDO.  She has twenty-five plus years of international business development experience in cannabis\, agriculture\, wellness\, green energy\, and food industries. She has had leadership roles on projects in corporate America and for the US Foreign Ag Service in over 10 countries\, in startups\, a state agency and non-profits; as well as worked for foreign governments and met with international leaders in Cuba\, Mexico\, and the Dominican Republic to open trade and advance development programs.  She has worked on investment projects in 8 countries. \nA lay expert in medical cannabis\, she is the author of the book Chronic Relief: A Guide to Cannabis for the Terminally & Chronically Ill and the curator of the informational website MyChronicRelief.com. Whiteley lives in Texas where she is an advocate for cannabis law reform and sits on the board of the Foundation for an Informed Texas\, a cannabis advocacy organization. Whiteley has been a contributing writer at ProjectCBD and is a speaker/educator dedicated to helping patients and caregivers bridge the gap between cannabis science and safe practical application.  Whiteley became a cannabis advocate\, author and speaker after her mother experienced great relief from cannabis at the end of her battle with lung cancer. \nShe has a Master of Agriculture from Texas A&M University\, a Bachelor of Science from Tarleton State University and is a graduate of the professional development program Texas Agricultural Lifetime Leadership hosted by the Texas A&M University System’s AgriLife Extension. URL:https://www.cannabisclinicians.org/event/special-edition-of-journal-club-dr-ethan-russo-nishi-whiteley-on-cannabinoid-hyperemesis-syndrome/ LOCATION:Zoom ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/05/cannabinoid-hyperemesis-syndrome-ethan-russo.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210722T090000 DTEND;TZID=America/Los_Angeles:20210722T100000 DTSTAMP:20260604T121701 CREATED:20210526T130228Z LAST-MODIFIED:20210526T130228Z UID:10000083-1626944400-1626948000@www.cannabisclinicians.org SUMMARY:Canna Talk with Frye & Wilson-King: Ethan Russo\, MD & Endocannabinoid Deficiency DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the July edition of “Canna Talk with Frye and Wilson-King” on July 22nd as we explore Clinical Endocannabinoid Deficiency with Ethan Russo\, MD\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Russo and discuss his line of research on the topic of Clinical Endocannabinoid Deficiency and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Russo presented in the SCC Clinical Training Module Clinical Endocannabinoid Deficiency. Learn more about Dr. Russo in the bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nEthan Russo\, MD is a board-certified neurologist\, psychopharmacology researcher\, and author. He is the Founder and CEO of Credo Science. \nPreviously\, he was Director of Research and Development of the International Cannabis and Cannabinoids Institute (ICCI) based in Prague\, Czech Republic. Medical Director of PHYTECS (2015-2017)\, a biotechnology company researching and developing innovative approaches targeting the human endocannabinoid system\, and from 2003-2014\, he served as Senior Medical Advisor\, medical monitor and study physician to GW Pharmaceuticals\, United Kingdom for numerous Phase I-III clinical trials of Sativex® for alleviation of cancer pain unresponsive to optimized opioid treatment and initial studies of Epidiolex® for intractable epilepsy. \nHe graduated from the University of Pennsylvania (Psychology)\, and the University of Massachusetts Medical School\, before residencies in Pediatrics in Phoenix\, Arizona and in Child and Adult Neurology at the University of Washington in Seattle. He was a clinical neurologist in Missoula\, Montana for 20 years in a practice with a strong chronic pain component. In 1995\, he pursued a 3-month sabbatical doing ethnobotanical research with the Machiguenga people in Parque Nacional del Manu\, Peru. \nHe has held faculty appointments in Pharmaceutical Sciences at the University of Montana\, in Medicine at the University of Washington\, and as visiting professor\, Chinese Academy of Sciences\, Harvard University\, and Johns Hopkins University. \nHe is a Past-President of the International Cannabinoid Research Society and is former Chairman of the International Association for Cannabinoid Medicines. He serves on the Scientific Advisory Board for the American Botanical Council. He is author of Handbook of Psychotropic Herbs\, co-editor of Cannabis and Cannabinoids: Pharmacology\, Toxicology and Therapeutic Potential\, and author of The Last Sorcerer: Echoes of the Rainforest. He was founding editor of Journal of Cannabis Therapeutics\, selections of which were published as books: Cannabis Therapeutics in HIV/AIDS\, Women and Cannabis: Medicine\, Science and Sociology\, Cannabis: From Pariah to Prescription\, and Handbook of Cannabis Therapeutics: From Bench to Bedside. He has also published numerous book chapters\, and over fifty articles in neurology\, pain management\, cannabis\, and ethnobotany. His research interests have included correlations of historical uses of cannabis to modern pharmacological mechanisms\, phytopharmaceutical treatment of migraine and chronic pain\, herbal synergy and phytocannabinoid/terpenoid\, serotonergic and vanilloid interactions. \nHe has consulted or lectured on these topics in 44 US states and Canadian provinces and 44 countries on six continents. URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-ethan-russo-md-endocannabinoid-deficiency/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210711T100000 DTEND;TZID=America/Los_Angeles:20210711T120000 DTSTAMP:20260604T121701 CREATED:20210621T062606Z LAST-MODIFIED:20210624T090550Z UID:10000086-1625997600-1626004800@www.cannabisclinicians.org SUMMARY:Quarterly Meeting: Emerging Indications for Medical Cannabis in Older Adults with Addie Ron\, MD DESCRIPTION:Join us for our quarterly meeting\, available to all SCC members. Addie Ron\, MD is the featured speaker who will be exploring: Emerging Indications for Medical Cannabis in Older Adults. \nDr. Ron will talk about the major indications for medical cannabis in older adults and share some of his  published and unpublished data\, including real life stories from his practice. Read more about Dr. Ron in the bio below. \nThe meeting is remote and free to all SCC members. Non members can also join for $10. Members can log in to the membership portal for instructions on how to join. \n  \nRSVP >> \n  \n \nAddie Ron\, MD is an Israeli physician certified in Geriatrics and Family Medicine. He holds a Master’s degree in Gerontology from Haifa University and completed a Geriatrics fellowship program at Boston University Medical Center. Doctor Ron is a practicing clinician for the last 20 years working at Maccabi Health Services\, the second largest HMO in Israel. In 2017 he entered the cannabis field as well by joining Niamedic as the Medical Director. NiaMedic is a medical data company offering healthcare\, research & consultation services in the cannabis field. As a Geriatrician Doctor Ron focused on treating older adults with Medical Cannabis while collecting data and following hundreds of patients. He recently published with his colleagues a summary article: Medical Cannabis for Older Patients Treatment Protocol and Initial Results (J Clin Med 2019 Nov 1; 8(11):1819.). Doctor Ron continues his practice and research in treating older adults with medical cannabis and is now cooperating with Tikun Olam on summarizing the effect of medical cannabis in reducing polypharmacy. URL:https://www.cannabisclinicians.org/event/quarterly-meeting-emerging-indications-for-medical-cannabis-in-older-adults-with-addie-ron-md/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/06/Quarterly-Meeting-website-banner.jpg ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210702T090000 DTEND;TZID=America/Los_Angeles:20210702T100000 DTSTAMP:20260604T121701 CREATED:20201120T170946Z LAST-MODIFIED:20210616T090325Z UID:10000063-1625216400-1625220000@www.cannabisclinicians.org SUMMARY:Monthly Journal Club: James Lowder\, MD & Patrick Tso\, PhD on Pharmacokinetics of Cannabinoids & the Lipid Absorption Pathway DESCRIPTION:9-10am PDT / 11am-1pm Colombia / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nPresenters:\nJames Lowder\, MD & Patrick Tso\, PhD (bios below) \nTopic:\nPharmacokinetics of Cannabinoids & the Lipid Absorption Pathway \nArticles to be Discussed:\n\nHuman Metabolites of Cannabidiol: A Review on Their Formation\, Biological Activity\, and Relevance in Therapy\nThe Pharmacokinetics and the Pharmacodynamics of Cannabinoids\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nJames N. Lowder\, MD is a board-certified oncologist trained at Case Western Reserve University and Stanford University\, formerly on the staff of the Cleveland Clinic. He has worked in development in the pharmaceutical and diagnostic industry for 30 years and is currently the Chief Medical Officer at Impact-Naturals\, a company developing cannabinoid products for use\nin the enhancement of life-style and personal health. Impact-Naturals aims to produce products which are designed using scientific principles throughout their journey from inception to the hands of the customer. \n  \nPatrick Tso\, PhD graduated in 1978 from the University of Western Australia in Physiology working under Professor W.J. Simmonds. His thesis work was on the role of biliary lecithin on the formation and secretion of chylomicrons. He has worked extensively with the gastrointestinal tract and the lymphatic system (over 40 years)\, especially the absorption of lipids. He has published at length on the formation and secretion of chylomicrons and the process regulating it. He was awarded the Distinguished Research prize from the American Physiological Society for his work on apolipoprotein A-IV. Over the years\, his laboratory has pioneered a number of concepts and approaches to study intestinal fat absorption. He has over 20 years on various NIH Study Sections and 4 years on the NIDDK Council\, and has consulted with a number of pharmaceutical companies including: Ajinomoto of Japan\, Lilly\, Johnson and Johnson\, Pfizer\, Upjohn\, Catalent\, Abbott Nutrition\, Merck\, Sankyo. He is currently the Mary Emery Professor of Pathology. URL:https://www.cannabisclinicians.org/event/monthly-journal-club-july/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210624T090000 DTEND;TZID=America/Los_Angeles:20210624T100000 DTSTAMP:20260604T121701 CREATED:20210526T085834Z LAST-MODIFIED:20210526T132822Z UID:10000082-1624525200-1624528800@www.cannabisclinicians.org SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis Dosing with Deborah Malka\, MD DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the June edition of “Canna Talk with Frye and Wilson-King” on June 24th as we explore the nuances of cannabis dosing with Deborah Malka\, MD\, PhD.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Malka and discuss how she was introduced to cannabinoid medicine\, what inspired her particular specialty\, and clinical pearls she learned along the way. We will have the opportunity to delve deeper into the topics Dr. Malka presented in her SCC Clinical Training Module Dosage and Delivery of Cannabis Medicine. Learn more about Dr. Malka in the bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nDeborah Malka MD\, PhD is a board-certified specialist in Integrative Holistic Medicine and has made it a priority to support patient empowerment and alternative medicine throughout her career. She has specialized in cannabis medical consultations for the past 15 years\, consulting with over 30\,000 patients to date. Her private practice\, CANNABIS PLUS\, provides medical cannabis and natural health consulting for a national client base via phone or telemedicine appointments. She is both a clinician and an educator in this specialty. She previously served as the medical director for a group of clinics providing medical marijuana evaluations in California\, training 50 physicians and serving over 300\,000 patients. She was the faculty director of the first comprehensive on-line continuing medical education course in Clinical Cannabinoid Medicine sponsored by the Society of Cannabis Clinicians. She is currently completing a manuscript for medical professionals in cannabis medicine. \nPrior to clinical practice\, Dr. Malka completed her PhD in Human Genetics from Columbia University\, and studied both natural and traditional medicine\, with degrees from the University of New Mexico School of Medicine and the Santa Fe College of Natural Medicine. The field of cannabis medicine allows her to integrate her expertise in allopathic medicine\, herbal medicine\, research\, education and patient care. It is her hope that patients will have the experience of finding alternatives to dependence on pharmaceuticals and discover the benefits of choosing healthier options\, including this most powerful herbal medicine\, cannabis. URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-dosing-with-deborah-malka-md/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210618T090000 DTEND;TZID=America/Los_Angeles:20210618T103000 DTSTAMP:20260604T121701 CREATED:20210520T135915Z LAST-MODIFIED:20210520T153943Z UID:10000080-1624006800-1624012200@www.cannabisclinicians.org SUMMARY:Premier Screening of "Synergy": 1st documentary on the Science of Cannabis in Perú DESCRIPTION:9am PDT /11am Peru/6pm CEST \nJoin the Society of Cannabis Clinicians for the English language premier of the first Peruvian documentary examining the science of cannabis. “Synergy” follows SCC Latin American Chapter member Dr. Max Alzamora and his work with cancer patients in Peru. The documentary highlights the potential benefits of cannabis in oncology\, the long regulatory process in the country\, and future aspirations to improve access to medical cannabis. \nAccording to the Center of Cannabis Studies in Peru\, cannabis has the potential to benefit around seven million people throughout the country. However\, only around 10\,000 patients are registered in the national data\, accounting for less than 1% of the population. The documentary acts as a way to help share knowledge about the benefits of cannabis medicine and encourage more research and compassionate laws for the patients of Peru. \nIn this one-time-only opportunity\, the SCC will present Synergy with its subtitles in English for the first time. The event will start with an introduction from Dr. Alzamora discussing the Peruvian experience of cannabis in clinical practice and why he decided to do the documentary. This will be followed by the documentary screening\, with time at the end for questions and answers. The event is free and open to the public. Sign up via the link below and watch the trailer here. \n  \nRSVP >> URL:https://www.cannabisclinicians.org/event/documentary-screening-medical-cannabis-in-peru-free/ ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/05/synergy-cannabis-documentary.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210616T090000 DTEND;TZID=America/Los_Angeles:20210616T110000 DTSTAMP:20260604T121701 CREATED:20210531T075213Z LAST-MODIFIED:20210609T064954Z UID:10000085-1623834000-1623841200@www.cannabisclinicians.org SUMMARY:International Veterinary Cannabis Roundtable Webinar DESCRIPTION:Topic: Legal Environment & Challenges Around the Globe\nHost: The SCC International Veterinary Cannabis Alliance\nConfirmed Panel Speakers: \n\nDr. Gary Richter (The Veterinary Cannabis Society – USA)\nDr. Patti Mayfield (The Veterinary Cannabis Society – USA)\nDr. Santiago Acosta (Asociación de Medicina Veterinaria Cannabinoide – LATAM)\nDr. Paula Lezcano (Asociación de Medicina Veterinaria Cannabinoide – LATAM)\nDr. Sarah Silcox (Canadian Association of Veterinary Cannabinoid Medicine)\n\nEvent Description:\nAs medicinal cannabis gains popularity and acceptance worldwide\, interest amongst the veterinary professional and pet loving communities is also increasing at an exponential rate. The newly emerging discipline of veterinary cannabis medicine is rapidly growing while traditional higher learning institutions and scientific research communities are struggling to keep up. This gap in education and scientific evidence\, combined with the slow-moving wheels of governmental regulation\, have created a field that is extremely confusing and challenging to navigate. Therefore\, in order to assist veterinary practitioners around the world\, the newly formed International Veterinary Cannabis Alliance is embarking on a series of roundtable discussions to help fill the current gaps in knowledge and expand our collective wisdom. \nThis series will feature internationally recognized veterinary cannabis experts and pioneers from around the globe who will address the various issues the profession is facing in their respective countries. Through solution-oriented discussions\, we aim to share best practices and tools for advancing and defending veterinarians’ rights to discuss cannabis medicine as a treatment option. \nWe will explore various topics including: \n\nNavigating legal challenges\nProduct quality concerns\nResearch studies and clinical trials\nIndividual case reports\nThe nuances of implementing cannabis in practice\nWhat the future holds for veterinary cannabis medicine\nAnd more.\n\nThis first web-based roundtable discussion will feature an international panel of experts who will address the current legal environment surrounding cannabis for veterinarians throughout the world. They will also explore the ramifications of integrating medical cannabis into the practice of veterinary medicine. \nJoin us as we share knowledge\, insight\, and valuable experience in what promises to be an enlightening and informative panel discussion. This inaugural event is free and open to all. \nRSVP >> URL:https://www.cannabisclinicians.org/event/international-veterinary-cannabis-roundtable-webinar/ ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/05/Vet-Medicine-Event-TW-2.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210604T090000 DTEND;TZID=America/Los_Angeles:20210604T100000 DTSTAMP:20260604T121701 CREATED:20201120T170920Z LAST-MODIFIED:20210526T080013Z UID:10000062-1622797200-1622800800@www.cannabisclinicians.org SUMMARY:Monthly Journal Club: Cannabis Nomenclature & Product Standardization with Kenzi Riboulet-Zemouli DESCRIPTION:9-10am PST / 11am-12pm CST / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nPresenter:\nKenzi Riboulet-Zemouli (bio below) \nTopic:\nIdentifying a coherent nomenclature cannabis products \nArticle to be Discussed:\n\n‘Cannabis’ ontologies I: Conceptual issues with Cannabis and cannabinoids terminology\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nLearn more about SCC membership options. \n  \nREGISTRATION >> \n  \nKenzi Riboulet-Zemouli is a French-Algerian interdisciplinary researcher and advocate for sustainable drug policy reforms. He co-founded the French NGO NORML France and the think-tank FAAAT. Focused on Action research (matching scholars and citizens) as a catalyser for legal and social changes\, Kenzi has been particularly involved in studying alternative pathways for Cannabis policy reform\, linking international law with local grassroots initiatives. His work articulates around ethics\, human rights aspects\, fair trade components\, and criteria of sustainability of legally-regulated use\, production\, and markets of internationally controlled and/or psychoactive plants\, fungi\, products or substances. URL:https://www.cannabisclinicians.org/event/monthly-journal-club-june/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210527T090000 DTEND;TZID=America/Los_Angeles:20210527T100000 DTSTAMP:20260604T121701 CREATED:20210409T102717Z LAST-MODIFIED:20210526T130802Z UID:10000077-1622106000-1622109600@www.cannabisclinicians.org SUMMARY:Canna Talk with Frye & Wilson-King: Cannabis & Mental Health with Dr. Zach Walsh DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the May edition of “Canna Talk with Frye and Wilson-King” on May 27th as we explore cannabis and mental health with Zach Walsh\, PhD\, RPsych.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr. Walsh and discuss how he was introduced to cannabinoid medicine\, what inspired his particular specialty\, and clinical pearls he learned along the way. We will have the opportunity to delve deeper into the topics Dr. Walsh presented in his two SCC Clinical Training Modules Cannabis & Mental Health 1: PTSD & Schizophrenia and Cannabis & Mental Health 2: Stress\, Depression\, Anxiety & Insomnia. Learn more in his bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nZach Walsh\, PhD\, RPsych is a clinical psychologist\, a Research Affiliate with the BC Centre on Substance Use\, and a Professor of Psychology at the University of British Columbia\, where he directs the Therapeutic\, Recreational\, and Problematic Substance Use lab. He has published and presented widely on topics related to cannabis\, psychedelics\, mental health and psychotherapy. He has been lead investigator for several ongoing studies of the therapeutic use of cannabis including a clinical trial of cannabis for PTSD\, and ongoing studies of the impacts of cannabis legalization of cannabis and of cannabis use among Canadian First Nations. Zach has provided invited consultations on medical cannabis use to the Canadian House of Commons and Senate\, the Uruguayan Ministry of Health and other international organizations. URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-cannabis-mental-health-with-dr-zach-walsh/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Bogota:20210510T170000 DTEND;TZID=America/Bogota:20210511T210000 DTSTAMP:20260604T121701 CREATED:20210420T141746Z LAST-MODIFIED:20210422T101705Z UID:10000078-1620666000-1620766800@www.cannabisclinicians.org SUMMARY:Cannabis for Epilepsy in Veterinary Medicine DESCRIPTION:Español abajo \nThe Latin American Association of Cannabinoid Veterinary Medicine presents a certified academic program created for medical professionals to navigate the use of cannabis for epilepsy in animals. Epilepsy is a one of the most common conditions in veterinary medicine.  The intention of this seminar is to give veterinarians the tools to address this condition from many different angles. \nThe seminar is two days long\, four hours each day. This course will explore epilepsy from a holistic approach with cannabis. Experts in the field of cannabinoid veterinary medicine will describe the science and how this may apply to clinical practice. The course features three members of the SCC Latin America Chapter\, Dr. Santiago Acosta\, Dr. Juan Lock\, and Dr. Jose Massabo. \nCost \n$35 (launch price until April 25th)\n$50 (full price) \nFor more information and to register\, visit the link below. \nSIGN UP >> \n  \nEPILEPSIA Y CANNABIS EN LA CLINICA VETERINARIA \nLa Asociación de Medicina Veterinaria Cannabinoide de Latinoamérica presenta este programa académico certificado de 8 horas creado para comprender una condición que es de una muy alta incidencia en la clínica veterinaria\, la epilepsia. De esta forma estructuramos un programa para médicos veterinarios que permite abordar esta enfermedad desde todos sus flancos. \nLos días 10 y 11 de mayo a a las 17:00 horas Colombia – México tendremos dos jornadas de de 4 horas en las cuales vamos a hacer un recorrido holístico por esta condición y la manera de abordarla con #CannabisMedicinal de la mano de grandes exponentes expertos en cada uno de sus temas. \nVALOR: \nUS$35\n(Precio de lanzamiento hasta abril 25) \nUS$50\n(Precio full) \n  \nINSCRIPCIÓN >> URL:https://www.cannabisclinicians.org/event/cannabis-for-epilepsy-in-veterinary-medicine/ ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/04/cannabis-epilepsy-in-animals.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210507T090000 DTEND;TZID=America/Los_Angeles:20210507T100000 DTSTAMP:20260604T121701 CREATED:20201120T170855Z LAST-MODIFIED:20210506T113748Z UID:10000061-1620378000-1620381600@www.cannabisclinicians.org SUMMARY:Grand Rounds: Clinical Case Presentations DESCRIPTION:9-10am PST / 11am-12pm CST / 12-1pm EST / 5-6pm UK \nBased on SCC member requests for a Grand Rounds webinar to present clinical cases and treatment of these particular patients\, our organization will host a pilot event on Friday\, May 7\, 2021 at 9am PST / 12pm EST. Journal Club will continue in June and be held on the first Friday of every month. \nPresenters:\n\nFrederick Slezak\, MD – Crohn’s Disease & Abdominal Pain: A Case Study\nCarolina Nocetti\, MD – An Integrative Approach to Alzheimer’s Disease Treatment\nKent Crowley\, PharmD – Cannabis Use in the Treatment of Pancreatic Cancer\n\n \nThe SCC provides a safe clinical space for members to have open discussions to share challenges\, observations\, and clinical pearls with cannabinoid-based medicines. This event will provide an opportunity to share clinical case reports from members\, ask questions\, and create an opportunity for a dynamic discussion. \nZOOM LINK >> URL:https://www.cannabisclinicians.org/event/grand-rounds-clinical-case-presentations/ LOCATION:Zoom ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/event-page-image-template.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/New_York:20210429T120000 DTEND;TZID=America/New_York:20210430T170000 DTSTAMP:20260604T121701 CREATED:20210405T164239Z LAST-MODIFIED:20210405T164239Z UID:10000076-1619697600-1619802000@www.cannabisclinicians.org SUMMARY:National Medical Cannabis Unity Conference DESCRIPTION:The Americans for Safe Access 9th Annual National Medical Cannabis Unity Conference will begin on April 29\, corresponding to the end of the first 100 days of the new Biden administration. This year’s Americans for Safe Access Unity Conference theme is “No Patient Left Behind”. Despite increasing legal access across the country\, patients still face significant barriers\, and there are many actions both Congress and the Biden-Harris administration can and should take to save lives right now. \nThis is an online conference and does not require travel or accommodations to attend. Just internet access. \nThis online conference will feature panel discussions with question time\, breakout sessions for attendees\, and expert-led workshops. \nRegister >> URL:https://www.cannabisclinicians.org/event/national-medical-cannabis-unity-conference/ ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/04/Screenshot-2021-04-05-at-18.36.46.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210422T090000 DTEND;TZID=America/Los_Angeles:20210422T100000 DTSTAMP:20260604T121701 CREATED:20210319T121129Z LAST-MODIFIED:20210422T113212Z UID:10000075-1619082000-1619085600@www.cannabisclinicians.org SUMMARY:Canna Talk with Frye & Wilson-King: Neurodegenerative & Movement Disorders with Dr. Stacey Kerr DESCRIPTION:As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our webinar series “Meet the Authors”\, will give participants a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the April edition of “Canna Talk with Frye and Wilson-King” on April 22nd as we explore Neurodegenerative & Movement Disorders with  Stacey Kerr\, MD.\nThese educational webinars are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with Dr.Kerr and discuss how she was introduced to cannabinoid medicine\, what inspired her to focus on their particular specialty\, and clinical pearls she has learned along the way. This month\, will have the opportunity to delve deeper into the topics Dr. Kerr presented in Cannabis in the Management of Neurodegenerative & Movement Disorders. Learn more in her bio below. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. Join us by registering via the link below. \n  \nREGISTRATION >> \n  \nDr Stacey Marie Kerr\, MD is a teacher\, author\, and family physician who was in private practice until she decided to write and educate full-time. She is a graduate of UC Davis Medical School. After several years working with the Society of Cannabis Clinicians and co-developing the first comprehensive online course in cannabinoid medicine\, she moved on to serve as the Medical Advisor for Hawaiian Ethos\, LLC on the Big Island of Hawaii. Currently she is a freelance physician practicing with a special interest in the medicinal use of cannabis. URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-neurological-movement-disorders-with-stacey-kerr/ ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/CannaTalk-website-banner.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210402T090000 DTEND;TZID=America/Los_Angeles:20210402T100000 DTSTAMP:20260604T121701 CREATED:20201120T170831Z LAST-MODIFIED:20210330T115344Z UID:10000060-1617354000-1617357600@www.cannabisclinicians.org SUMMARY:Monthly Journal Club: Cannabis in Oncology with Katia Tonkin\, MD DESCRIPTION:9-10am PST / 11am-12pm CST / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club meets monthly the first Friday of every month. Presentations will focus on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. \nPresenter:\nKatia Tonkin\, MD (bio below) \nTopic:\nMedical Cannabis in Oncology \nArticles Discussed:\n\nMedical Oncologists’ Views on the Utility of Medical Marijuana Across the Cancer Trajectory\nAppraising the “entourage effect”: Antitumor action of a pure cannabinoid versus a botanical drug preparation in preclinical models of breast cancer\n\nFREE for SCC members. $10 for non members.  \nWant to sign up to present an article? Contact us here. \nThe Journal Club is open to SCC members only. Learn more about SCC membership options. \n  \nREGISTRATION >> \n  \nKatia Tonkin\, MBBS\, MD\, FRCPC\, FRCP (UK) is a medical oncologist who worked at The Cross Cancer Institute in Edmonton Alberta Canada for 20 years and in London\, Ontario Canada for six years prior to that. She did her medical oncology training at The Princess Margaret Hospital in Toronto Ontario and has dual UK and Canadian oncology qualifications. Dr. Tonkin was involved for 30 years in clinical trials that specialized in breast and gynecological cancers. \nShe has a master’s degree from two years spent in the lab studying chemotherapy and radiation effects in immune compromised mice. \nShe became interested in medical cannabis in 2016 as many patients started asking about cannabis. After researching into it\, Dr. Tonkin felt cannabis was likely to help many patients with a wide variety of problems. \nShe started treating patients in April 2017 and wants to pursue clinical research to further medical knowledge into appropriate uses of medical cannabis. Dr. Tonkin’s goal is to help uncover the true benefits and side effects of cannabis beyond the already very useful pragmatic clinical approach. URL:https://www.cannabisclinicians.org/event/monthly-journal-club-april/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/11/Monthly-Journal-Club-2-scaled.jpg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210325T090000 DTEND;TZID=America/Los_Angeles:20210325T100000 DTSTAMP:20260604T121701 CREATED:20210301T093524Z LAST-MODIFIED:20210319T085725Z UID:10000073-1616662800-1616666400@www.cannabisclinicians.org SUMMARY:Canna Talk with Frye & Wilson-King: Debut Webinar DESCRIPTION:The Society of Cannabis Clinicians brings you a new online show series\, “Canna Talk with Frye and Wilson-King”. As part of our continued efforts to share more information about the clinical evidence covered in the SCC’s Clinical Training Curriculum\, our new webinar series “Meet the Authors”\, will give our viewers a unique opportunity to experience discussion with experts in the field of medical cannabis. \nDon’t miss the first edition of “Canna Talk with Frye and Wilson-King” on March 25th as we explore Cannabis\, Women’s Health\, Pregnancy\, and Breastfeeding.\nThese educational webinars will occur on the fourth Thursday of each month at 9am PST/12pm EST and are free for all to attend. The curriculum co-directors Patricia Frye\, MD and Genester Wilson-King\, MD will host informal conversations with course authors on each episode of the series. We will uncover how each author was introduced to cannabinoid medicine\, what inspired them to focus on their particular specialty\, and clinical pearls that they have learned along the way. Expert guests on the show will have the opportunity to delve deeper into the topics they presented in their modules. \nEstablished cannabis clinicians as well as individuals new to the medical cannabis sphere are all invited to attend this conversation as we learn and grow together. This is a great platform for users who are enrolled in the Training Curriculum to ask follow-up questions that may have come up while they were taking the courses. Questions can be submitted beforehand or asked live during the webinar. \nSubscribe to our weekly newsletter to learn more and be sure to connect with us on social media. Please join us for the premier debut of Canna Talk by registering via the link below. \n  \nREGISTRATION >> URL:https://www.cannabisclinicians.org/event/canna-talk-with-frye-wilson-king-debut-webinar/ ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/free-webinar-cannabis-courses.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Mexico_City:20210318T110000 DTEND;TZID=America/Mexico_City:20210318T130000 DTSTAMP:20260604T121701 CREATED:20210304T152313Z LAST-MODIFIED:20211223T182404Z UID:10000074-1616065200-1616072400@www.cannabisclinicians.org SUMMARY:Latin American Virtual Seminar on Medical Cannabis: A New Medical Field DESCRIPTION:English below \n1er. Seminario Virtual Latinoamericano Cannabis Medicinal: Una Nueva Área de la Medicina\nDescripción:\nLa Sociedad Mexicana de Cannabis Medicinal invita a este Primer Seminario Virtual en compañía de expertos de América Latina para conocer más acerca de los retos y las mayores oportunidades en la integración de esta nueva área a la práctica profesional de médicos y otros profesionales de la salud en el continente. \nConferencias:\n\nDra. Sandra Carrillo– Preseidente dela Asociación Médica Colombiana de Cannabis Medicinal y miembro del cápitulo latinoamericano de la SCC\nDr. Facundo Álvarez– Cofundador y Vicepresidente de Cannamerica y miembro del cápitulo latinoamericano de la SCC\nJosé Lugardo\, MS- Director de Grupo Sativa Health y Secretario de SOMEXCANN\nNicole Halcartégaray\, PhD– Coordinadora de investigación de Fundación Daya\,\nDr. Rubén Pagaza– Vicepresidente de la Sociedad Mexiana de Cannabis Medicinal\n\nEl evento es gratis. \nLatin American Virtual Seminar on Medical Cannabis: A New Medical Field\nDescription:\nIn this First Seminar\, the Mexican Medical Cannabis Society (SOMEXCANN) and members of the Society of Cannabis Clinicians open a dialogue about the endocannabinoid system and cannabis therapeutics with leading experts on cannabis in clinical practice in Latin American. The webinar will discus clinical experience with medical cannabis as well as opportunities for the Mexico-Colombia-Chile-Argentina block to lead the way in advancing evidence-based and patient-centered guidelines. The event will be held in Spanish. \nThe Seminar is moderated by José Lugardo\, M.S.\, CEO of Grupo Sativa Health and Secretary of the Mexican Medical Cannabis Society (SOMEXCANN). \nPanelists\n\nDr. Sandra Carrillo– Preseident of la Asociación Médica Colombiana de Cannabis Medicinal and member of the SCC Latin America chapter\nDr. Facundo Álvarez– Co-Founder and Vicepresident of Cannamerica and the SCC Latin American chapter\nJosé Lugardo\, MS- Director of Grupo Sativa Health and Secretary of SOMEXCANN\nNicole Halcartégaray\, PhD– Research Coordinator o Fundación Daya\,\nDr. Rubén Pagaza– Vice-president of the Sociedad Mexiana de Cannabis Medicinal\n\nThe event is free and created for physicians and Healthcare Professionals URL:https://www.cannabisclinicians.org/event/latin-american-virtual-seminar-on-medical-cannabis-a-new-medical-field/ ATTACH;FMTTYPE=image/png:https://www.cannabisclinicians.org/wp-content/uploads/2021/03/Screenshot-2021-03-04-at-16.12.03.png END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210307T120000 DTEND;TZID=America/Los_Angeles:20210307T140000 DTSTAMP:20260604T121701 CREATED:20201013T114324Z LAST-MODIFIED:20210225T111505Z UID:10000044-1615118400-1615125600@www.cannabisclinicians.org SUMMARY:SCC Quarterly Meeting: Dr. Julie Holland on Cannabis and Connection DESCRIPTION:Join us for our quarterly meeting\, available to all SCC members. Dr. Julie Holland is the featured speaker. She will be exploring: Cannabis and Connection – Therapy in Troubled Times. \nWhy does hugging feel so good? Why are cannabis sales skyrocketing in our time of social isolation? The pleasure of social interactions are enabled by not only oxytocin\, but also the endocannabinoid system. Dr. Holland will discuss her private psychiatric practice and how cannabis medicine fits into her framework of the chemistry of connection. (Extensive Q & A and interactive discussion to follow a mercifully brief and non-powerpoint presentation.) Read more about Dr. Holland in the bio below. \nThe meeting is remote and available to all SCC members. Members can log in to the membership portal for instructions on how to join. \n  \nRSVP >> \n  \n \nJulie Holland\, MD is a psychiatrist specializing in psychopharmacology with a private practice in New York City. Her book Weekends at Bellevue chronicles her nine years running the psychiatric emergency room as an attending physician on the faculty of NYU School of Medicine. Frequently featured on the Today show and CNN’s documentary series “Weed\,” Holland is the editor of The Pot Book and Ecstasy: The Complete Guide. (Both books are non-profit projects that help to fund clinical therapeutic research.) \nDr. Holland is the medical monitor for several MAPS PTSD studies utilizing MDMA-assisted psychotherapy or testing varieties of cannabis with varying CBD/THC ratios. She has worked for decades on US drug policy reform based on harm reduction principles. \nHer 2016 book\, Moody Bitches: The Truth About the Drugs You’re Taking\, the Sleep You’re Missing\, the Sex You’re Not Having\, and What’s Really Making You Crazy has been translated into eleven languages. Her most recent book\, Good Chemistry: The Science of Connection\, From Soul to Psychedelics was published in June 2020. URL:https://www.cannabisclinicians.org/event/scc-quarterly-meeting-dr-julie-holland/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/10/Julie-Holland-cannabis-speaker.jpg ORGANIZER;CN="Society of Cannabis Clinicians":MAILTO:info@cannabisclinicians.org END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210305T090000 DTEND;TZID=America/Los_Angeles:20210305T100000 DTSTAMP:20260604T121701 CREATED:20201120T170806Z LAST-MODIFIED:20210217T082432Z UID:10000059-1614934800-1614938400@www.cannabisclinicians.org SUMMARY:Monthly Journal Club DESCRIPTION:9-10am PST / 11am-12pm CST / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club focuses on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month features Dave Gordon MD\, IFMCP\, ABoIM discussing the applications of medical cannabis on fibromyalgia. Learn more about Dr. Gordon in the bio below. \nArticles to be discussed: \n\n– Ingestion of a THC-Rich Cannabis Oil in People with Fibromyalgia: A Randomized\, Double-Blind\, Placebo-Controlled Clinical Trial  \n– Safety and Efficacy of Medicinal Cannabis in the Treatment of Fibromyalgia: A Systematic Review \n\nWant to sign up to present an article? Contact us here. \nThe Journal Club is open to SCC members only. Learn more about SCC membership options. \nZOOM LINK FOR MEMBERS >> \n  \nDr. Dave Gordon has more than 20 years experience working with patients. His passion is providing non-pharmaceutical options for chronic disease prevention\, treatment and reversal\, using 4 Pillars — food\, movement\, relaxation & community — as cornerstones of an integrative approach. \nHe received his Medical Doctorate and completed residency training at the University of Colorado and remains on the clinical faculty. Dr. Dave is board-certified in Internal and Integrative Medicine and a Certified Functional Medicine Practitioner with the Institute of Functional Medicine. \nCurrently\, Dr. Dave provides medical cannabis and integrative medicine consultations at 4 Pillars Health & Wellness\, the practice he owns and operates. He is also the Medical Director at Revive Treatment Centers\, a world-renowned neurological rehabilitation and optimization facility that transforms the lives of brain injury survivors. \nFor over 10 years\, Dr. Dave has reviewed research on cannabis and our endocannabinoid system and witnessed the safety and effectiveness of cannabis while working with patients. He serves on the advisory board of Leaf 411\, a non-profit that provides education and directional support to the general public about the safe use of legal cannabis. He is excited to be on the forefront of cannabis medicine\, bringing that knowledge to patients\, practitioners\, and the general public. URL:https://www.cannabisclinicians.org/event/monthly-journal-club-march/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/07/pexels-photo-1106468.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210212T090000 DTEND;TZID=America/Los_Angeles:20210212T100000 DTSTAMP:20260604T121701 CREATED:20201120T170714Z LAST-MODIFIED:20210210T081229Z UID:10000058-1613120400-1613124000@www.cannabisclinicians.org SUMMARY:Monthly Journal Club DESCRIPTION:9-10am PST / 11am-12pm CST / 12-1pm EST / 5-6pm UK \nThe SCC Journal Club focuses on a variety of articles and perspectives related to cannabis medicine\, including but not limited to clinically-relevant articles and research methodology-focused papers. This month features Jacqueline Jacques\, ND\, FTOS discussing updates on cannabis and obesity. Learn more about Dr. Jacques in the bio below. \nArticles to be discussed: \n\n\nEffects of Perioperative Cannabis Use on Bariatric Surgical Outcomes: a Systematic Review\nAssociations Between Cannabis Use\, Abdominal Fat Phenotypes and Insulin Traits\nCannabis Associated with Lower BMI\n\n\nWant to sign up to present an article? Contact us here. \nThe Journal Club is open to SCC members only. Learn more about SCC membership options. \n  \nZOOM LINK FOR MEMBERS >> \n  \nDr. Jacqueline Jacques is a Naturopathic Doctor and Fellow of the Obesity Society with over 20 years of expertise in medical nutrition. She is currently the Chief Medical Officer of CB2 therapeutics\, a joint venture between Thorne Research and Tetra Bio-Pharma\, developing novel therapeutics that act via the endocannabinoid system. Dr Jacques has spent much of her career in the dietary supplement industry as a formulator\, speaker\, writer\, and executive\, including being a co-founder of Bariatric Advantage (now a division of Metagenics\, Inc). She has appeared as a guest on radio and television\, and has spoken nationally and internationally to health professionals and the public alike. She is the author of the book Micronutrition for the Weight Loss Surgery Patient\, and has contributed to numerous other professional publications. Additionally\, she has served on the boards/advisory boards for the United Way of Orange County (Community Impact)\, Obesity Action Coalition\, the Samueli Center for Integrative Medicine\, Alkemist Labs\, YOR Health\, Bodywise International\, and the California Naturopathic Doctors Association. URL:https://www.cannabisclinicians.org/event/monthly-journal-club-february/ LOCATION:Zoom ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/07/pexels-photo-1106468.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210209T100000 DTEND;TZID=America/Los_Angeles:20210209T223000 DTSTAMP:20260604T121701 CREATED:20201218T131946Z LAST-MODIFIED:20201218T131946Z UID:10000072-1612864800-1612909800@www.cannabisclinicians.org SUMMARY:Cannabis\, Equity\, & Racial Justice DESCRIPTION:10am-11:30am PST\, 12-1:30pm Central\, 1-2:30 EST\, 6-7:30pm BST\, 7-8:30pm CEST \nJoin California organizers and advocates for 8 free virtual convenings (60-90 min each) to learn about Prop. 64 implementation and build our movement to repair the harm caused by the War on Drugs by centering racial justice\, equity\, and healing. \nSession #8 \nAdvancing Healing-Centered and Trauma-informed Approaches \nThis session will explore a roadmap for how organizations can build a sustainable\, culturally-responsive\, racially just\, healing-centered\, trauma-informed approach to engaging and supporting youth. This session will also address how organizations can integrate the principles and recommendations from the roadmap and practices into their organizational culture and internal practices. Presenters: Kanwarpal Dhaliwal\, RYSE\, Dr. Christina Bethell\, Child and Adolescent Health Measurement Initiative \nINFO & REGISTRATION >> URL:https://www.cannabisclinicians.org/event/cannabis-equity-racial-justice-2-2-2-2-2-2/ LOCATION:Online ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/12/https___cdn.evbuc_.com_images_120284203_350585137707_1_original.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210204T100000 DTEND;TZID=America/Los_Angeles:20210204T223000 DTSTAMP:20260604T121701 CREATED:20201218T131809Z LAST-MODIFIED:20201218T131809Z UID:10000071-1612432800-1612477800@www.cannabisclinicians.org SUMMARY:Cannabis\, Equity\, & Racial Justice DESCRIPTION:10am-11:30am PST\, 12-1:30pm Central\, 1-2:30 EST\, 6-7:30pm BST\, 7-8:30pm CEST \nJoin California organizers and advocates for 8 free virtual convenings (60-90 min each) to learn about Prop. 64 implementation and build our movement to repair the harm caused by the War on Drugs by centering racial justice\, equity\, and healing. \nSession #7 \nBuilding People Power and Coalitions to Advance Equity and Racial Justice \nIn this session\, we will discuss how we can continue to advance policy in support of equity and justice as the cannabis sector grows and generates more profits. After a brief introduction\, we will break into four regions (Nor Cal\, Central Valley\, LA and So Cal) so that participants can begin the process of connecting with one another and learning about one another’s efforts. In closing\, we will share opportunities on the horizon to further advance equity in cannabis policy. Presenters: Marc Philpart\, ABMoC\, Jim Keddy and Sarah-Michael Gaston\, Youth Forward\, and Malaki Seku Amen\, California Urban Partnership \nINFO & REGISTRATION >> URL:https://www.cannabisclinicians.org/event/cannabis-equity-racial-justice-2-2-2-2-2/ LOCATION:Online ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/12/https___cdn.evbuc_.com_images_120284203_350585137707_1_original.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210202T100000 DTEND;TZID=America/Los_Angeles:20210202T223000 DTSTAMP:20260604T121701 CREATED:20201218T131711Z LAST-MODIFIED:20201218T131711Z UID:10000070-1612260000-1612305000@www.cannabisclinicians.org SUMMARY:Cannabis\, Equity\, & Racial Justice DESCRIPTION:10am-11:30am PST\, 12-1:30pm Central\, 1-2:30 EST\, 6-7:30pm BST\, 7-8:30pm CEST \nJoin California organizers and advocates for 8 free virtual convenings (60-90 min each) to learn about Prop. 64 implementation and build our movement to repair the harm caused by the War on Drugs by centering racial justice\, equity\, and healing. \nSession #6 \nThe Cannabis Industry\, Equity and Public Health \nThe cannabis industry is evolving in ways that are increasing health risks to youth. This session will explore the harmful impact of high potency THC products on youth mental health\, cannabis industry marketing strategies\, and the negative effects of use on pregnant women. Presenters will share recommendations on how local groups can spread awareness of these concerns and organize to regulate the local industry. Presenters: Dr Lynn Silver\, Public Health Institute \nINFO & REGISTRATION >> URL:https://www.cannabisclinicians.org/event/cannabis-equity-racial-justice-2-2-2-2/ LOCATION:Online ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/12/https___cdn.evbuc_.com_images_120284203_350585137707_1_original.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210128T100000 DTEND;TZID=America/Los_Angeles:20210128T223000 DTSTAMP:20260604T121701 CREATED:20201218T131343Z LAST-MODIFIED:20201218T131343Z UID:10000069-1611828000-1611873000@www.cannabisclinicians.org SUMMARY:Cannabis\, Equity\, & Racial Justice DESCRIPTION:10am-11:30am PST\, 12-1:30pm Central\, 1-2:30 EST\, 6-7:30pm BST\, 7-8:30pm CEST \nJoin California organizers and advocates for 8 free virtual convenings (60-90 min each) to learn about Prop. 64 implementation and build our movement to repair the harm caused by the War on Drugs by centering racial justice\, equity\, and healing. \nSession #5 \nLocal Cannabis Tax Revenues: Threat and Opportunity \nAcross the state\, local governments are collecting local tax revenue and are using those funds to support general government and to expand law enforcement. Local groups organizing or preparing to organize to redirect local cannabis taxes away from law enforcement and toward community reinvestment will share their experiences. In addition\, presenters will share new research on how numerous local governments are currently spending tax revenues. Presenters: Jim Freeman\, Grassroots Action Support Team\, Jim Keddy and Sarah-Michael Gaston\, Youth Forward and local organizers \nINFO & REGISTRATION >> URL:https://www.cannabisclinicians.org/event/cannabis-equity-racial-justice-2-2-2/ LOCATION:Online ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/12/https___cdn.evbuc_.com_images_120284203_350585137707_1_original.jpeg END:VEVENT BEGIN:VEVENT DTSTART;TZID=America/Los_Angeles:20210121T100000 DTEND;TZID=America/Los_Angeles:20210121T223000 DTSTAMP:20260604T121701 CREATED:20201218T131055Z LAST-MODIFIED:20201218T131206Z UID:10000068-1611223200-1611268200@www.cannabisclinicians.org SUMMARY:Cannabis\, Equity\, & Racial Justice DESCRIPTION:10am-11:30am PST\, 12-1:30pm Central\, 1-2:30 EST\, 6-7:30pm BST\, 7-8:30pm CEST \nJoin California organizers and advocates for 8 free virtual convenings (60-90 min each) to learn about Prop. 64 implementation and build our movement to repair the harm caused by the War on Drugs by centering racial justice\, equity\, and healing. \nSession #4 \nThe Status of EQUITY in California’s Marijuana Industry and Policies: \nThis presentation will report on how Black and Brown cannabis entrepreneurs are struggling to access capital\, adequate technical support and equitable regulations in order to enter and participate meaningfully in California’s marijuana industry. We will provide an overview of the state equity grants program and efforts in several parts of the state to increase equity in cannabis business development. Finally\, we will look at practices\, trends and policy ideas that are emerging to help close the racial wealth gaps caused by the criminalization of weed. Presenters: Malaki Seku Amen\, California Urban Partnership and The Institute for MORE \nINFO & REGISTRATION >> URL:https://www.cannabisclinicians.org/event/cannabis-equity-racial-justice-2-2/ LOCATION:Online ATTACH;FMTTYPE=image/jpeg:https://www.cannabisclinicians.org/wp-content/uploads/2020/12/https___cdn.evbuc_.com_images_120284203_350585137707_1_original.jpeg END:VEVENT END:VCALENDAR